Publications by authors named "Hannah Hicks"

Article Synopsis
  • Thyroid cancer is on the rise and is one of the most lethal forms of endocrine cancer, but there's a lack of effective treatments targeting the MAPK pathway for advanced cases.
  • In a study, researchers found that combining BRAF and MEK1/2 inhibitors significantly reduced cell growth in most tested mutant thyroid cancer cell lines and effectively inhibited the MAPK pathway.
  • To combat drug resistance, they identified downregulation of Aurora Kinase B in sensitive cells and demonstrated that inhibiting Aurora Kinase B alongside MEK1/2 could lead to increased apoptosis, suggesting a new potential treatment strategy for patients with mutant thyroid cancer.
View Article and Find Full Text PDF

Unlabelled: Mutations in BRAF are common in advanced papillary and anaplastic thyroid cancer (PTC and ATC). However, patients with BRAF-mutant PTC currently lack therapies targeting this pathway. Despite the approved combination of BRAF and MEK1/2 inhibition for patients with BRAF-mutant ATC, these patients often progress.

View Article and Find Full Text PDF

Historians have recognized the importance of enslaved African American healers, including conjure practitioners who drew on herbal and ritual remedies, in providing a "dual system of health care" for enslaved people in the American South. Planters' journals and narratives by formerly enslaved people alike include accounts of antebellum conjurers as health practitioners. After Emancipation, African American conjurers remained integral, particularly in rural Black communities where people had little contact with orthodox physicians.

View Article and Find Full Text PDF

Mutations in the BRAF gene are highly prevalent in thyroid cancer. However, the response rate of thyroid tumors to BRAF-directed therapies has been mixed. Increasingly, combination therapies inhibiting the MAPK pathway at multiple nodes have shown promise.

View Article and Find Full Text PDF

Invasive lobular carcinoma of the breast (ILC) is strongly estrogen-driven and represents a unique context for estrogen receptor (ER) signaling. In ILC, ER controls the expression of the Wnt ligand WNT4, which is critical for endocrine response and anti-estrogen resistance. However, signaling mediated by WNT4 is cell type- and tissue-specific, and has not been explored in ILC.

View Article and Find Full Text PDF
Article Synopsis
  • * Recent research has highlighted the critical role of epigenetic mechanisms in FP-RMS, suggesting potential therapeutic targets, but their intricate workings are still being studied.
  • * The study identifies an epigenetic interaction involving the factors KDM3A and Ets1 that enhances the expression of disease-promoting genes associated with the PAX3/FOXO1 fusion, indicating that targeting this axis could lead to new treatment
View Article and Find Full Text PDF

The growth and reactive dewetting of ultrathin films of iron oxides supported on Re(0001) surfaces have been imaged in situ in real time. Initial growth forms a nonmagnetic stable FeO (wüstite like) layer in a commensurate network upon which high aspect ratio nanowires of several microns in length but less than 40 nm in width can be fabricated. The nanowires are closely aligned with the substrate crystallography and imaging by X-ray magnetic circular dichroism shows that each contain a single magnetic domain.

View Article and Find Full Text PDF